CN Patent

CN110818705A — 缬苯那嗪的盐型和相应晶型与其制备方法

Assigned to SUZHOU PENGXU PHARMATECH Co Ltd · Expires 2020-02-21 · 6y expired

What this patent protects

本申请提供化合物缬苯那嗪的几种盐型和晶型及其制备方法。本申请所涉及的化合物缬苯那嗪成盐和结晶方法，可以有效提高药物活性分子缬苯那嗪的纯度，操作简便，有利于工业化生产。

USPTO Abstract

本申请提供化合物缬苯那嗪的几种盐型和晶型及其制备方法。本申请所涉及的化合物缬苯那嗪成盐和结晶方法，可以有效提高药物活性分子缬苯那嗪的纯度，操作简便，有利于工业化生产。

Drugs covered by this patent

valbenazine-tosylate (VALBENAZINE TOSYLATE)

Patent Metadata

Patent number: CN110818705A
Jurisdiction: CN
Classification: —
Expires: 2020-02-21
Drug substance claim: No
Drug product claim: No
Assignee: SUZHOU PENGXU PHARMATECH Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.